ID   2LMP
AC   CVCL_EQ20
SY   2-LMP
DR   cancercelllines; CVCL_EQ20
DR   GEO; GSM1401670
DR   Wikidata; Q54584606
RX   PubMed=9739048;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 16
//
RX   PubMed=9739048; DOI=10.1172/JCI3492;
RA   Zhai Y.-F., Guo R.-B., Hsu T.-L., Yu G.-L., Ni J., Kwon B.S.,
RA   Jiang G.-W., Lu J., Tan J., Ugustus M., Carter K., Rojas L., Zhu F.,
RA   Lincoln C., Endress G., Xing L., Wang S., Oh K.-O., Gentz R.,
RA   Ruben S.M., Lippman M.E., Hsieh S.-L., Yang D.-J.;
RT   "LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM
RT   induces apoptosis and suppresses in vivo tumor formation via gene
RT   transfer.";
RL   J. Clin. Invest. 102:1142-1151(1998).
//